WASHINGTON, May 5 (Reuters) - Pharmaceutical company Vivus Inc (VVUS.O) on Monday filed to sell up to $150 million in common stock. Vivus said in a filing with the U.S. Securities and Exchange Commission that it plans to use the …
If you want a Stock Review on GRFS, HALO, ILMN, or VVUS then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Thursday, benchmark US indices were in bullish colors as the …
If you want a Stock Review on GRFS, HALO, ILMN, or VVUS then come over to http://dailystocktracker.com/register/ …
CNBC's Seema Mody looks at three stocks to watch tomorrow, including Illumina, the day's worst performing stock on the Nasdaq 100; Netflix, which was down again; and Vivus, which was downgraded today.
SL, Fort Lauderdale Dear SL: The reason a stock trades at the price it does today is that right ... which he says could either zoom and boom or crash and smash. Vivus (VVUS-$1.19), founded in 1991, is a $125 million-revenue …
MicroStockProfit.com announces an investment report featuring VIVUS Inc. (Nasdaq:VVUS). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment …
VIVUS, Inc. and Alvogen Malta Operations Ltd, today announced an agreement under which Alvogen will market Qsymia® in the Republic of Korea for the treatment of chronic weight... VIVUS (VVUS) reported earnings about a month ago. …
Mr. David York Norton is Chairman of the Board and Director of Vivus, Inc., since July 19, 2013. Until his retirement in September 2011, Mr. Norton was Company Group Chairman, Global Pharmaceuticals for Johnson & Johnson, a multi …
these are the four most volatile stocks with significant volume, providing ample intra-day opportunity for traders. BlackBerry (Nasdaq:BBRY) is prone to having some large intra-day moves. Based on the criterion, this is the most …